Original source text
© Tinpixels / Getty ImagesEastman Chemical (NYSE: EMN | EMN Price Prediction) is a Kingsport, Tennessee specialty materials company whose molecular recycling (methanolysis) facility is reshaping its cash flow profile. Trading at $72.49 with a 4.56% yield, the question for income investors is straightforward: can the company keep funding the payout through a cyclical chemicals trough?
Dividend Snapshot Metric Value Annual Dividend $3.34 Dividend Yield 4.56% Consecutive Years of Increases 16 years Most Recent Quarterly Rate $0.84 (ex-date June 15, 2026) Dividend Aristocrat Status No (needs 25 years) The Cash Flow Math Works, Even in a Down Year Eastman paid $381 million in dividends in 2025 against $424 million in free cash flow (operating cash flow of $970 million minus capex of $546 million). FY2025 adjusted EPS came in at $5.42, while the dividend run rate is roughly $3.32 per share.
Metric Value Assessment Earnings Payout (Adj.) ~61% Healthy FCF Payout ~90% Elevated OCF Coverage 2.5x Strong The FCF cushion narrowed in 2025 versus $688 million in 2024, but 2026 capex guidance of about $400 million should restore breathing room.
Leverage Is the Real Watch Item Metric Value Net Debt $4.59B EBITDA (TTM) $1.37B Net Debt / EBITDA ~3.4x Cash on Hand (Q1 2026) $665M Leverage above 3x EBITDA is elevated for a cyclical, but the $665 million cash balance and targeted $125 to $150 million in 2026 cost reductions provide insulation.
16 Straight Raises, Including Through 2020 Year Annual Dividend Paid 2025 $381M 2024 $379M 2023 $376M 2022 $381M 2021 $375M The quarterly rate has climbed from $0.46 in 2016 to $0.84 today, and management held the line through the pandemic.
Management Calls Out the Catalyst CEO Mark Costa said on the FY2025 call: “We continued to prioritize stockholder returns and raised the dividend for the 16th consecutive year. In total, we returned approximately $500 million through dividends and share repurchases.” He added: “In 2025, we generated operating cash flow approaching $1 billion, a clear validation of our disciplined approach to cost and working capital management.” The Kingsport methanolysis facility, contributing about $60 million of incremental earnings in 2025 with $30 million more targeted in 2026, is the secular growth engine.
Verdict: Safe, With Leverage as the Asterisk Dividend Safety Rating: Safe. The adjusted-earnings payout near 61% is comfortable, OCF covered the dividend 2.5x, and the recycling ramp adds structural cash flow. EMN screens favorably for income if the methanolysis economics and 11x forward P/E mark a cyclical trough. The risk case builds if olefin pricing weakens further and net debt drifts above $4.59 billion, which would pressure capital allocation. For now, the payout is well covered.